Friday, November 7, 2025
wellness India Expo
Home Tags Trials

Tag: Trials

Datavant and Indegene partner to power more efficient clinical trial recruitment

Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials

Roche partners 10 govt hospitals to strengthen clinical trial capabilities in...

Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 Trials

Sun Pharma’s phase 3 trials of ILUMYA support potential U.S. submission...

Both pivotal studies met their primary endpoint with statistically significant improvements based on ACR20 response rates at Week 24 with tildrakizumab 100 mg (ILUMYA) compared to placebo

Auriga Research signs strategic MoU with San Francisco Research Institute

The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and international business development

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction & a safety...

Lilly plans to submit efsitora for the treatment of adults with type 2 diabetes to global regulatory agencies by the end of this year

Parexel completes CDSCO registration

The registration under the new G.S.R 581(E) regulation reflects Parexel’s commitment to regulatory compliance and clinical research excellence in India

Philogen completes patient enrollment of Phase III FIBROSARC trial in soft...

All ongoing Fibromun trials are expected remain on track with their expected timelines

“There is a growing trend towards outsourcing clinical trials to India”

Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook

Parexel names Keri Mattox as Chief Business Officer

Healthcare executive to lead company’s business operations and growth strategy

Ahammune Biosciences raises USD 5 million in series A funding led...

The recently raised funding will assist the company in conducting human clinical trials for its promising drug candidate in vitiligo patients